Published in Can J Gastroenterol on March 01, 2011
Tea and human health: biomedical functions of tea active components and current issues. J Zhejiang Univ Sci B (2015) 0.91
Adverse effects of plant food supplements and botanical preparations: a systematic review with critical evaluation of causality. Br J Clin Pharmacol (2015) 0.84
Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics. Int J Mol Sci (2016) 0.82
Acute liver failure and self-medication. Arq Bras Cir Dig (2015) 0.80
Repeated dose studies with pure Epigallocatechin-3-gallate demonstrated dose and route dependant hepatotoxicity with associated dyslipidemia. Toxicol Rep (2016) 0.76
Urticarial vasculitis induced by OTC diet pills: a case report. World Allergy Organ J (2015) 0.75
Hypericum perforatum-induced hepatotoxicity with possible association with copaiba (Copaifera langsdorffii Desf):case report. Einstein (Sao Paulo) (2014) 0.75
Induction of fatty liver by Coleus forskohlii extract through enhancement of de novo triglyceride synthesis in mice. Toxicol Rep (2014) 0.75
Urticarial rashes following guggulu intake: A case report. J Ayurveda Integr Med (2017) 0.75
Herbal remedies. N Engl J Med (2002) 4.90
Herbal hepatotoxicity. J Hepatol (2005) 3.98
Acute liver failure induced by green tea extracts: case report and review of the literature. Liver Transpl (2006) 2.13
Severe hepatotoxicity associated with the dietary supplement LipoKinetix. Ann Intern Med (2002) 2.06
Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Ann Intern Med (2006) 1.95
Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea. Eur J Gastroenterol Hepatol (2005) 1.31
Herbal hepatotoxicity. Semin Liver Dis (2002) 1.30
Hepatotoxic slimming aids and other herbal hepatotoxins. J Gastroenterol Hepatol (2008) 1.21
Toxicity of green tea extracts and their constituents in rat hepatocytes in primary culture. Food Chem Toxicol (2005) 1.14
Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all. J Hepatol (2009) 1.12
Hepatotoxicity and complementary and alternative medicines. Clin Liver Dis (2003) 1.02
Severe hepatotoxicity associated with use of a dietary supplement containing usnic acid. Mayo Clin Proc (2006) 1.02
Usnic acid-induced necrosis of cultured mouse hepatocytes: inhibition of mitochondrial function and oxidative stress. Biochem Pharmacol (2004) 0.98
[Liver toxicity of Camellia sinensis dried etanolic extract]. Med Clin (Barc) (2003) 0.93
Fulminant liver failure due to usnic acid for weight loss. Am J Gastroenterol (2004) 0.91
Unexplained severe illness possibly associated with consumption of Kombucha tea--Iowa, 1995. MMWR Morb Mortal Wkly Rep (1995) 0.88
Idiosyncratic toxicity: a convergence of risk factors. Annu Rev Med (2007) 0.87
[Acute hepatitis due to Exolise, a Camellia sinensis-derived drug]. Gastroenterol Clin Biol (2003) 0.85
Metabolism and related human risk factors for hepatic damage by usnic acid containing nutritional supplements. Xenobiotica (2008) 0.80
'Fat burner' herb, usnic acid, induced acute hepatitis in a family. J Gastroenterol Hepatol (2005) 0.78
Role of transposable elements in heterochromatin and epigenetic control. Nature (2004) 10.51
Transplant tourism in China: a tale of two transplants. Am J Bioeth (2010) 6.67
Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature (2010) 4.78
Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science (2008) 4.71
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl (2012) 4.65
Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell (2009) 4.52
Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature (2004) 4.41
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis. N Engl J Med (2015) 3.13
ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci U S A (2007) 2.85
TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer. Proc Natl Acad Sci U S A (2010) 2.72
Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology (2006) 2.62
Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev (2007) 2.60
Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell (2003) 2.53
Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy. Hepatology (2014) 2.28
Factors that predict outcome of abdominal operations in patients with advanced cirrhosis. Clin Gastroenterol Hepatol (2009) 2.18
Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology (2009) 2.05
Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. Cancer Res (2012) 2.00
Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl (2012) 1.90
Epithelial-mesenchymal transition, cancer stem cells and treatment resistance. Breast Cancer Res (2012) 1.68
High-throughput selection of effective RNAi probes for gene silencing. Genome Res (2003) 1.65
Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition. Cancer Res (2012) 1.57
Inducible, reversible, and stable RNA interference in mammalian cells. Proc Natl Acad Sci U S A (2004) 1.55
Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. Biochim Biophys Acta (2009) 1.54
Id1 restrains p21 expression to control endothelial progenitor cell formation. PLoS One (2007) 1.52
The beneficial impact of temporary porto-caval shunt in orthotopic liver transplantation: a single center analysis. Transpl Int (2010) 1.48
Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg (2004) 1.36
Nitric oxide activates diverse signaling pathways to regulate gene expression. J Biol Chem (2003) 1.22
A comparison of coronal plane axial femoral relationships in Asian patients with varus osteoarthritic knees and healthy knees. J Arthroplasty (2008) 1.21
MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells. Cancer Res (2012) 1.21
Quality of life after lobectomy for adult liver transplantation. Transplantation (2002) 1.15
Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration. Cancer Cell (2013) 1.14
Geographic disparity: the dilemma of lower socioeconomic status, multiple listing, and death on the liver transplant waiting list. Clin Transplant (2014) 1.14
The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome. Blood (2009) 1.13
Endothelial progenitor cells are cellular hubs essential for neoangiogenesis of certain aggressive adenocarcinomas and metastatic transition but not adenomas. Proc Natl Acad Sci U S A (2008) 1.13
Selective alpha-particle mediated depletion of tumor vasculature with vascular normalization. PLoS One (2007) 1.08
The variable pathology of kidney disease after liver transplantation. Transplantation (2010) 1.08
The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression. Trends Mol Med (2009) 1.05
Discovery of novel human breast cancer microRNAs from deep sequencing data by analysis of pri-microRNA secondary structures. PLoS One (2011) 1.05
Use of locking compression plates for long bone nonunions without removing existing intramedullary nail: review of literature and our experience. J Trauma (2008) 1.03
Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transpl (2009) 1.02
Isolated intestinal transplantation: proof of clinical efficacy. Transplantation (2003) 1.00
Using the transcription factor inhibitor of DNA binding 1 to selectively target endothelial progenitor cells offers novel strategies to inhibit tumor angiogenesis and growth. Cancer Res (2010) 1.00
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth. J Natl Cancer Inst (2010) 0.98
Gender-specific high-flexion knee prosthesis in Indian women: a prospective randomised study. J Orthop Surg (Hong Kong) (2012) 0.97
Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation. Liver Transpl (2013) 0.96
Achalasia in a patient with gastroesophageal varices: problematic treatment decisions. Dig Dis Sci (2006) 0.96
Complicated hernia presentation in patients with advanced cirrhosis and refractory ascites: management and outcome. Surgery (2010) 0.96
Hoffa fracture with ipsilateral patellar dislocation resulting from household trauma. Can J Surg (2009) 0.95
Bone marrow-derived Gr1+ cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1. Cancer Discov (2013) 0.94
Delivery of gene silencing agents for breast cancer therapy. Breast Cancer Res (2013) 0.94
Clinical factors that predict noncirrhotic portal hypertension in HIV-infected patients: a proposed diagnostic algorithm. J Infect Dis (2013) 0.94
Clinical characterization of patients developing histologically-proven fibrosing cholestatic hepatitis C post-liver transplantation. Hepatol Res (2011) 0.94
Liver and skin histopathology in adults with acid sphingomyelinase deficiency (Niemann-Pick disease type B). Am J Surg Pathol (2012) 0.93
Early and frequent histological recurrence of Crohn's disease in small intestinal allografts. Transplantation (2005) 0.91
Stem cells: Metabolism regulates differentiation. Nat Chem Biol (2010) 0.90
Underreporting of liver transplant waitlist removals due to death or clinical deterioration: results at four major centers. Transplantation (2013) 0.89
The incidence and significance of late acute cellular rejection (>1000 days) after liver transplantation. Clin Transplant (2004) 0.88
Distinct sites on G protein beta gamma subunits regulate different effector functions. J Biol Chem (2002) 0.88
Total hip arthroplasty following failed fixation of proximal hip fractures. Indian J Orthop (2008) 0.88
Hepatocellular carcinoma in type 1 Gaucher disease: a case report with review of the literature. Semin Liver Dis (2005) 0.87
Hepatocellular carcinoma associated with an atypical presentation of Wilson's disease. Semin Liver Dis (2007) 0.87
Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients. Breast Cancer Res Treat (2011) 0.86
Minimally invasive plate osteosynthesis using a locking compression plate for diaphyseal humeral fractures. J Orthop Surg (Hong Kong) (2012) 0.85
Recurrent hepatic sarcoidosis post-liver transplantation manifesting with severe hypercalcemia: a case report and review of the literature. Liver Transpl (2005) 0.84
The impact of costimulatory molecule gene polymorphisms on clinical outcomes in liver transplantation. Am J Transplant (2003) 0.83
Intestinal transplantation before and after the introduction of sirolimus. Transplantation (2002) 0.83
An integrated approach to intestinal failure: results of a new program with total parenteral nutrition, bowel rehabilitation, and transplantation. J Gastrointest Surg (2002) 0.82
Budd-Chiari syndrome in sarcoidosis involving liver. Liver Int (2008) 0.82
Prophylactic use of antibiotic-loaded bone cement in primary total knee arthroplasty: Justified or not? Indian J Orthop (2009) 0.81
A single nucleotide polymorphism of Toll-like receptor 4 identifies the risk of developing graft failure after liver transplantation. J Hepatol (2010) 0.81
The association of IL28B polymorphism and graft survival in patients with hepatitis C undergoing liver transplantation. PLoS One (2013) 0.80
ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipients. Transplantation (2006) 0.79
An escalating dose regimen of pegylated interferon and ribavirin in HCV cirrhotic patients referred for liver transplant. Transplantation (2009) 0.78
Pretransplant immunomodulation of highly sensitized small bowel transplant candidates with intravenous immune globulin. Transplantation (2006) 0.78
Peginterferon-α-2b and ribavirin for hepatitis C recurrence postorthotopic liver transplantation. J Clin Gastroenterol (2012) 0.78
Segment 4 and the left lateral segment regeneration pattern after resection of the middle hepatic vein in a living donor right hepatectomy. HPB (Oxford) (2014) 0.78
Tumor microenvironment regulates epithelial-mesenchymal transitions in metastasis. Expert Rev Anticancer Ther (2012) 0.78
Telaprevir-induced DRESS. J Drugs Dermatol (2014) 0.77
Insulin resistance and clustering of atherogenic risk factors in women belonging to low socio-economic strata in urban slums of North India. Diabetes Res Clin Pract (2002) 0.76
Hepatoportal sclerosis (obliterative portal venopathy) and nodular regenerative hyperplasia in a patient with myasthenia gravis: A case report and review of the published work. Hepatol Res (2013) 0.76
Recognition of nonhepatic coma in the setting of acetaminophen overdose. Dig Dis Sci (2005) 0.76
Lamivudine resistance leading to de novo hepatitis B infection in recipients of hepatitis B core antibody positive liver allografts. Hepatol Res (2013) 0.75
Moral complexity and the delusion of moral purity. Am J Bioeth (2010) 0.75
Human peritoneal macrophages from ascitic fluid can be infected by a broad range of HIV-1 isolates. J Acquir Immune Defic Syndr (2010) 0.75
Is there a better way to monitor abstinence among substance abusers awaiting transplantation? Curr Opin Organ Transplant (2012) 0.75
Complement component C3 allotypes and outcomes in liver transplantation. Liver Transpl (2010) 0.75
Ascites and variceal bleeding occurring in a 20-year-old with cystic fibrosis. Hepatology (2009) 0.75
Comparative study of the results of compound tibial shaft fractures treated by Ilizarov ring fixators and limb reconstruction system fixators. Chin J Traumatol (2015) 0.75
Orthotopic liver transplantation for adults with Alagille syndrome. Clin Transplant (2011) 0.75
Is cholecystostomy a safe procedure in patients with cirrhosis? Am Surg (2014) 0.75
A woman with chronic anemia and cholestatic liver disease. Hepatology (2009) 0.75
Steatohepatitis secondary to long-term glucocorticoid treatment for congenital adrenal hyperplasia: a potential diagnostic pitfall. Semin Liver Dis (2013) 0.75
Acute cellular rejection and its sequelae developing in a 42-year-old man after liver transplantation. Hepatology (2009) 0.75
Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study. Eur J Gastroenterol Hepatol (2017) 0.75
A patient with no known liver disease presenting with a sentinel variceal hemorrhage. Hepatology (2009) 0.75
Jaundice developing in a patient with hepatitis C4 months after liver transplantation. Hepatology (2009) 0.75
A Real-World Evaluation of Repeat Paracentesis-guided Management of Spontaneous Bacterial Peritonitis. J Clin Gastroenterol (2017) 0.75
Multivisceral transplantation for portal hypertension and diffuse mesenteric thrombosis caused by protein C deficiency. Transplantation (2002) 0.75
An adolescent presenting with hematemesis and renal abnormalities. Hepatology (2009) 0.75